| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | |
|---|---|---|---|---|---|---|
ASSETS | ||||||
Current assets: | ||||||
Cash | ||||||
801 | 1,124 | 1,303 | 1,521 | 1,826 | 6 | |
Prepaid expenses | ||||||
106 | 50 | 64 | 108 | 142 | - | |
Total current assets | ||||||
907 | 1,174 | 1,367 | 1,629 | 1,968 | 6 | |
Deferred offering costs | ||||||
- | - | - | - | - | 232 | |
Cash and investments held in trust account | ||||||
309,160 | 307,338 | 306,394 | 305,017 | 303,682 | - | |
Total assets | ||||||
310,067 | 308,512 | 307,761 | 306,646 | 305,650 | 238 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
Current liabilities: | ||||||
Note payable to Sponsor | ||||||
- | - | - | - | - | 90 | |
Accounts payable | ||||||
53 | 46 | 13 | 26 | 53 | 27 | |
Accrued liabilities | ||||||
2,169 | 2,119 | 2,039 | 44 | 91 | 99 | |
Deferred compensation | ||||||
151 | 116 | 81 | 46 | - | - | |
Accrued income and franchise taxes | ||||||
395 | - | 65 | 27 | 117 | - | |
Total current liabilities | ||||||
2,768 | 2,281 | 2,198 | 143 | 261 | 216 | |
Other liabilities: | ||||||
Deferred underwriting compensation | ||||||
10,179 | 10,179 | 10,179 | 10,179 | 10,179 | - | |
Total liabilities | ||||||
12,947 | 12,460 | 12,377 | 10,322 | 10,440 | 216 | |
Common stock subject to possible redemption; 28,922,833 and 28,817,019 shares at March 31, 2020 and December 31, 2019, respectively, (at value of approximately $10.10 per share) | ||||||
292,120 | 291,052 | 290,384 | 291,324 | 290,210 | - | |
Stockholders' equity: | ||||||
Additional paid-in-capital | ||||||
2,773 | 3,842 | 4,510 | 3,569 | 4,684 | 24 | |
Retained earnings | ||||||
2,226 | 1,157 | 489 | 1,430 | 315 | -3 | |
Total stockholders' equity | ||||||
5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 22 | |
Total liabilities and stockholders' equity | ||||||
310,067 | 308,512 | 307,761 | 306,646 | 305,650 | 238 | |
Class B Common Stock | ||||||
Common stock | ||||||
1 | 1 | 1 | 1 | 1 | 1 | |
Total stockholders' equity | ||||||
1 | 1 | 1 | 1 | 1 | 1 | |